🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Giulia Cattaneo

Cedars-Sinai Medical Center

ORCID: 0000-0002-7053-3238

Also affiliated with Massachusetts General Hospital

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids”.

TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids

Cancer Immunology Research(2025)10.1158/2326-6066.cir-23-1011
N/A
0.530DataRank · unranked
15 citations

Luke Maggs, Apekshya Panda, Samuel J. Wright, Angelina M. Cicerchia, Anne Jenney +23 more

Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0071
N/A
0.515DataRank · unranked
30 citations

Giulia Cattaneo, Shahrzad Arya, Jingyu Jia, Maria Chiara Gelmi, Yi Sun +11 more

Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102210
N/A
0.382DataRank · unranked
9 citations

Angelina M. Cicerchia, Ofir Shorer, Claire A. Palin, Boryana Petrova, Seth Anderson +50 more

Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.12.579184
N/A
0.290DataRank · unranked
5 citations

Angelina M. Cicerchia, Ofir Shorer, Boryana Petrova, Seth Anderson, Joshua Park +48 more

Interplay between B7–H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma

Cancer Letters(2024)10.1016/j.canlet.2024.216713
N/A
0DataRank · unranked
6 citations

Marco Ventin, Shahrzad Arya, Filippos Kontos, Theodoros Michelakos, Yurie Sekigami +13 more

Neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma (PDAC) with germline DNA damage repair (DDR) mutations: A dual institution retrospective study.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.4164
N/A
0DataRank · unranked
1 citations

Marco Ventin, Giulia Cattaneo, Arya Shahrzad, Anser Abbas, Brent K. Larson +13 more

CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft-tissue sarcoma histotypes

UNC Libraries(2024)10.17615/ycg2-8e83
N/A
0DataRank · unranked
0 citations

Marco Basiricò, Ilenia Iaia, Valeria Leuci, Franca Fagioli, Ymera Pignochino +19 more

B7-H3 CAR-T cell therapy combined with irradiation is effective in targeting bulk and radiation-resistant chordoma cancer cells

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-009544
N/A
0DataRank · unranked
14 citations

David O. Osei-Hwedieh, Tara Walhart, Yin P. Hung, Yufeng Wang, Giulia Cattaneo +6 more

B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer

Journal of Experimental & Clinical Cancer Research(2025)10.1186/s13046-025-03475-8
N/A
0DataRank · unranked
4 citations

Marco Ventin, Shahrzad Arya, Cedric Bailey, Venkata R. Vantaku, Jingyu Jia +7 more

Molecular basis for targeting TBK1 in CAR-T cell therapies for cancer

Expert Opinion on Therapeutic Targets(2025)10.1080/14728222.2025.2545845
N/A
0DataRank · unranked
1 citations

Marco Ventin, Luke Maggs, Yi Sun, Cristina R. Ferrone, Russell W. Jenkins +1 more

CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0357
N/A
0DataRank · unranked
44 citations

Chiara Donini, Giovanni Grignani, Ramona Rotolo, Giulia Mesiano, Erika Fiorino +19 more

CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma

Frontiers in Neuroscience(2021)10.3389/fnins.2021.662064
N/A
0DataRank · unranked
149 citations

Giulia Cattaneo, Ali Emre Dal, Ali Sanjari Moghaddam, Soldano Ferrone, Luke Maggs

Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment

Nature Communications(2023)10.1038/s41467-023-41282-x
N/A
0DataRank · unranked
43 citations

David L. Drum, Ruochuan Sun, Yida Zhang, Feng Chen, Fengfei Sun +29 more